Zoghbi Karina Kuhl, Felipe Vinicius Cardona, Graziano Luciana, Guatelli Camila Souza, de Souza Juliana Alves, Bitencourt Almir Galvão Vieira
Graduate Program, A.C.Camargo Cancer Center, São Paulo, SP, Brazil.
Hospital Saúde da Mulher, Belém, PA, Brazil.
Radiol Bras. 2024 Apr 6;57:e20230111en. doi: 10.1590/0100-3984.2023.0111-en. eCollection 2024 Jan-Dec.
To evaluate the indications for and results of magnetic resonance imaging (MRI) examinations for breast cancer screening at a cancer center in Brazil.
This was a retrospective observational study, based on electronic medical records, of patients undergoing MRI for breast cancer screening at a cancer center in Brazil.
We included 597 patients between 19 and 82 years of age. The main indications for MRI screening were a personal history of breast cancer, in 354 patients (59.3%), a family history of breast cancer, in 102 (17.1%), and a confirmed genetic mutation, in 67 (11.2%). The MRI result was classified, in accordance with the categories defined in the Breast Imaging Reporting and Data System, as benign (category 1 or 2), in 425 patients (71.2%), probably benign (category 3), in 143 (24.0%), or suspicious (category 4 or 5), in 29 (4.9%). On MRI, 11 malignant tumors were identified, all of which were invasive carcinomas. Among those 11 carcinomas, six (54.5%) were categorized as minimal cancers (< 1 cm), and the axillary lymph nodes were negative in 10 (90.9%). The cancer detection rate was 18.4/1,000 examinations, and the positive predictive value for suspicious lesions submitted to biopsy was 37.9%.
In our sample, the main indication for breast MRI screening was a personal history of breast cancer. The results indicate that MRI is a highly accurate method for the early detection of breast neoplasms in this population.
评估巴西一家癌症中心进行乳腺癌筛查的磁共振成像(MRI)检查的适应症及结果。
这是一项基于电子病历的回顾性观察研究,研究对象为巴西一家癌症中心接受MRI乳腺癌筛查的患者。
我们纳入了597例年龄在19至82岁之间的患者。MRI筛查的主要适应症为乳腺癌个人史,共354例患者(59.3%);乳腺癌家族史,共102例(17.1%);以及确诊的基因突变,共67例(11.2%)。根据乳腺影像报告和数据系统定义的类别,MRI结果分类如下:425例患者(71.2%)为良性(1类或2类),143例(24.0%)为可能良性(3类),29例(4.9%)为可疑(4类或5类)。在MRI检查中,共发现11例恶性肿瘤,均为浸润性癌。在这11例癌中,6例(54.5%)被归类为微小癌(<1 cm),10例(90.9%)腋窝淋巴结阴性。癌症检出率为18.4/1000次检查,活检可疑病变的阳性预测值为37.9%。
在我们的样本中,乳腺MRI筛查的主要适应症是乳腺癌个人史。结果表明,MRI是该人群早期检测乳腺肿瘤的一种高度准确的方法。